Family Office · Fremantle, WA, Australia
Ridgeback Capital is a private investment firm specializing in the healthcare and life sciences sectors. Founded in 2006 and headquartered in New York City, the firm focuses on investing in innovative biotechnology, pharmaceutical, and medical device companies. Ridgeback Capital is known for its involvement in funding early-stage and growth-stage companies that are developing transformative therapies and technologies. The firm has played a notable role in supporting companies working on critical healthcare solutions, including those addressing infectious diseases and rare conditions.
We never publish partner emails directly — score your deck to unlock contacts for the firms ranked as best-fit.
Ridgeback Capital deploys privately-held capital. Cycles are short, decisions concentrated, and structures flexible (equity, convertible, revenue-share). Less brand premium, more underwriting on substance. Claude Fundraiser tracks Ridgeback Capital alongside 45,000+ other active investors, ranked weekly by recent-deal momentum, sector concentration, and partner activity.
Drop your pitch. Claude scores it on the 8 dimensions VCs read for and ranks the 45,000+ active investors in the database by fit. Ridgeback Capital is one of them — and we'll tell you exactly where they sit in your top 100.